Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074711 · ClinicalTrials.gov registry record · Phase 2
Adding Phosphorus to Osteoporosis Drug Treatment
A Phase 2 study of Osteoporosis and Osteopenia, sponsored by Creighton University.
- Completed
- Registry status
- Phase 2
- Development phase
- 241
- Enrollment target
- 1
- Study location
NCT00074711: Completed Phase 2 study of Osteoporosis and Osteopenia, sponsored by Creighton University.
NCT00074711 is a Phase 2 study of Osteoporosis and Osteopenia that has completed, run by Creighton University. The registered enrollment target is 241 participants, below the 1,543-participant average among 84 other Osteoporosis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00074711, a Phase 2 study of Osteoporosis and Osteopenia, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 241 participants
- Enrollment target
- 1
- Study location
Study Summary
Osteoporosis causes bones to weaken and break more easily. Calcium and phosphorus are two minerals that are essential for normal bone formation. Unfortunately, calcium salts commonly prescribed in anti-osteoporosis treatment bind phosphorus from food and restrict phosphorus available for bone building. Teriparatide is a drug that reduces the risk of fractures by increasing bone thickness and strength. Vitamin D is also necessary for strong bones and teeth. The purpose of this study is to evaluate the bone-building effectiveness of two calcium supplements, one with a source of phosphorus and one without, in combination with teriparatide and vitamin D in women with osteoporosis.
Primary Outcome
Bone mineral density (BMD, measured by dual X-ray absorptiometry - DEXA) measured at several intervals during the study. BMD measured as grams per square centimeter (g/cm2).
Conditions Studied
Interventions
- DRUG Calcium carbonate
- DRUG Calcium Phosphate
Study Locations (1)
Nebraska
- Creighton University Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00074711 record still lists
NCT00074711 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 1,543-participant average among 84 other Osteoporosis trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 2 interventions - of which Calcium carbonate is the first listed.
NCT00074711 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT00074711 about?
NCT00074711 is a clinical study titled "Adding Phosphorus to Osteoporosis Drug Treatment". Osteoporosis causes bones to weaken and break more easily. Calcium and phosphorus are two minerals that are essential for normal bone formation. Unfortunately, calcium salts commonly prescribed in anti-osteoporosis treatment bind phosphorus from food and restrict phosphorus available for bone buildi...
What is the current status of trial NCT00074711?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 241 participants. The study started on 2004-08. Estimated completion is 2008-06.
What conditions does trial NCT00074711 study?
This clinical trial studies the following conditions: Osteoporosis, Osteopenia.
What interventions are being tested in trial NCT00074711?
The interventions under investigation include: Calcium carbonate (DRUG), Calcium Phosphate (DRUG).
Who is sponsoring clinical trial NCT00074711?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00074711 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00074711's enrollment target sits among peer trials
241 28th of 84 higher than 57 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
RECRUITING · Phase 2
-
Calcium and Bone Mass in Young Females
COMPLETED · Phase 2
-
Comparison Study of PTHrP and PTH to Treat Osteoporosis
COMPLETED · Phase 2
-
Hormone Replacement Therapy to Treat Turner Syndrome
COMPLETED · Phase 2
-
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
COMPLETED · Phase 2
-
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia